Principal Investigator |
Institution |
Project |
Contact details |
Prof. Anna-Lise Williamson |
University of Cape Town |
Development of candidate HIV-1 subtype C vaccines for southern Africa |
annalise@curie.uct.ac.za
(021) 406 6124 |
Prof. Carolyn Williamson |
University of Cape Town |
HIV-1 diversity and vaccine immunogen design |
cwilliam@curie.uct.ac.za
(021) 406 6683 |
Prof. Lynn Morris |
National Research Institute for Communicable Diseases |
Development of envelope HIV vaccine candidates: neutralising antibody studies and development of monoclonal and polyclonal antibodies |
lynnm@nicd.ac.za
(011) 386 6332 |
Prof. Clive Gray |
National Institute for Communicable Diseases |
Understanding correlates of protection through analysis of HIV-specific T cell immune functions: development of novel immunogenicity markers |
cliveg@nicd.ac.za
(011) 386 6362 |
Prof. Debra Meyer |
University of Johannesburg |
Synthetic HIV-1 envelope based immunogens as vaccine components able to elicit broadly cross-neutralising antibody responses |
dm@rau.ac.za |
Dr Jo-Ann Passmore |
University of Cape Town |
Characterisation of mucosal and peripheral blood T cell responses in the control of HIV infection |
joann@curie.uct.ac.za |
Prof. Thumbi Ndung'u |
Nelson R. Mandela School of Medicine |
Definition of optimal immunogens for a protective HIV clade C virus vaccine |
ndungu@ukzn.ac.za |
Prof. Caroline Tiemessen |
National Institute for Communicable Diseases |
The role of chemokines CCL3/CC13-L1 in protective immunity and as adjuvants promoting immune responses to HIV-1 |
carolinet@nicd.ac.za |
Prof. S. P. Songca |
University of Limpopo |
The role of chemokines CCL3/CC13-L1 in protective immunity and as adjuvants promoting immune responses to HIV-1 |
songcasp@
medunsa.ac.za |
Prof. M. J. Mphahlele |
University of Limpopo |
HIV-1 diversity and vaccine immunogen design |
jmphahlele@
medunsa.ac.za |
Prof. Glenda Gray |
Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, University of the Witwatersrand |
Clinical trial unit for HIV vaccine trials |
gray@pixie.co.za
(011) 989 9703 |
Dr Linda-Gail Bekker |
University of Cape Town |
Clinical trial unit for HIV vaccine trials |
Linda-Gail.Bekker@
hiv-research.org.za
(021) 650 6962 |
Prof. Gavin Churchyard |
Aurum Institute for Health Research |
Clinical trial unit for HIV vaccine trials |
gchurchyard@
auruminstitute.org |
Prof. Jimmy Chandia |
Walter Sisulu University |
Early development of clinical trial site |
jrschandia@yahoo.com |
Dr Koleka Mlisana |
CAPRISA – Centre for the AIDS Programme of Research in South Africa |
Establishment of a clinical trial site |
Mlisanak@ukzn.ac.za |
Dr Maposhane Nchabeleng |
MEDUNSA |
Establishment of a clinical trial site |
nchabe@
medunsa.ac.za |
Dr Eftyhia Vardas |
Perinatal HIV Research Unit, University of the Witwatersrand |
Early development of a clinical trial site at Agincourt |
vardase@mweb.co.za |
Prof. Graham Lindegger |
HIV Vaccine Ethics Group (HAVEG), University of KwaZulu-Natal |
Strengthening ethical priority areas for South African HIV vaccine trials |
lindegger@ukzn.ac.za
(033) 260 5335 |
Prof. Leslie Swartz |
University of Stellenbosch |
Evaluating community interventions for community preparedness in HIV vaccines: towards best practice |
lswartz@sun.ac.za |
Prof. Priscilla Reddy |
Medical Research Council |
Gaining an understanding on the determinants of community-based vaccine trial participation behaviour: developing and testing a health education intervention using a randomised control trial |
priscilla.reddy@
mrc.ac.za |
Prof. Win Hide |
University of the Western Cape |
Bioinformatics |
winhide@sanbi.ac.za |
Ms Elise Levendal |
Medical Research Council |
Masikhulisane Community Involvement Programme |
Elise.levendal@
mrc.ac.za
(021) 938 0826 |
